CNTA

MKT CAP:$6B

Centessa Pharmaceuticals PLC ADR

Market Cap

$6B

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$39.70+$16.01 (+67.58%)

Jun 8, 2026

52W High $39.9052W Low $11.94

Company Details

Centessa Pharmaceuticals plc, together with its subsidiaries, discovers, develops, and delivers orexin-based neuroscience therapeutics in the United Kingdom and the United States. The company develops ORX750, an orexin receptor 2 agonist, w...

CEO

—

IPO Date

May 28, 2021

Website

centessa.com

Key Metrics TTM

Revenue

-100.0% YoY

Net Income

-$251M

EPS (Diluted)

Free Cash Flow

-$209M

Revenue / Share

$0.00

Gross Margin

Operating Margin

Net Margin

FCF Margin

P/S

P/E

Earnings Reports

Q1 2026

May 5, 2026

$0-100.0%

FY 2025

Mar 31, 2026

$15M

Q4 2025

Mar 31, 2026

$0-100.0%

Q3 2025

Nov 5, 2025

Q2 2025

Aug 12, 2025

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee